124 related articles for article (PubMed ID: 8190092)
21. Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulfide bridges are essential for receptor function.
Vilardaga JP; Di Paolo E; Bialek C; De Neef P; Waelbroeck M; Bollen A; Robberecht P
Eur J Biochem; 1997 May; 246(1):173-80. PubMed ID: 9210480
[TBL] [Abstract][Full Text] [Related]
22. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma.
Ding WQ; Cheng ZJ; McElhiney J; Kuntz SM; Miller LJ
Cancer Res; 2002 Sep; 62(18):5223-9. PubMed ID: 12234988
[TBL] [Abstract][Full Text] [Related]
23. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
24. Altered regulation of the D(1) dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity.
Ventura AL; Sibley DR
J Pharmacol Exp Ther; 2000 May; 293(2):426-34. PubMed ID: 10773012
[TBL] [Abstract][Full Text] [Related]
25. The somatostatin receptors SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase in Chinese hamster ovary cells via pertussis toxin-sensitive pathways.
Hershberger RE; Newman BL; Florio T; Bunzow J; Civelli O; Li XJ; Forte M; Stork PJ
Endocrinology; 1994 Mar; 134(3):1277-85. PubMed ID: 7907016
[TBL] [Abstract][Full Text] [Related]
26. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR
Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
Br J Pharmacol; 1998 Dec; 125(7):1463-70. PubMed ID: 9884074
[TBL] [Abstract][Full Text] [Related]
28. Desensitization of canine histamine H2 receptor expressed in Chinese hamster ovary cells.
Fukushima Y; Oka Y; Katagiri H; Saitoh T; Asano T; Ishihara H; Matsuhashi N; Kodama T; Yazaki Y; Sugano K
Biochem Biophys Res Commun; 1993 Feb; 190(3):1149-55. PubMed ID: 8382488
[TBL] [Abstract][Full Text] [Related]
29. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
Ozcelebi F; Holtmann MH; Rentsch RU; Rao R; Miller LJ
Mol Pharmacol; 1995 Nov; 48(5):818-24. PubMed ID: 7476911
[TBL] [Abstract][Full Text] [Related]
30. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
Ehlert FJ; Griffin MT; Glidden PF
J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
[TBL] [Abstract][Full Text] [Related]
31. Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretin.
Vilardaga JP; di Paolo E; de Neef P; Waelbroeck M; Bollen A; Robberecht P
Biochem Biophys Res Commun; 1996 Jan; 218(3):842-6. PubMed ID: 8579602
[TBL] [Abstract][Full Text] [Related]
32. Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
Rousseau G; Nantel F; Bouvier M
Mol Pharmacol; 1996 Apr; 49(4):752-60. PubMed ID: 8609905
[TBL] [Abstract][Full Text] [Related]
33. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P
J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
[TBL] [Abstract][Full Text] [Related]
34. Secretin receptors in a new preparation of plasma membranes from intrahepatic biliary epithelium.
Farouk M; Vigna SR; Haebig JE; Gettys TW; McVey DC; Chari R; Pruthi RS; Meyers WC
J Surg Res; 1993 Jan; 54(1):1-6. PubMed ID: 8094102
[TBL] [Abstract][Full Text] [Related]
35. The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.
Gourlet P; Vilardaga JP; De Neef P; Waelbroeck M; Vandermeers A; Robberecht P
Peptides; 1996; 17(5):825-9. PubMed ID: 8844773
[TBL] [Abstract][Full Text] [Related]
36. Failure of secretin to stimulate gastrin release and adenylate cyclase activity in gastrinoma in vitro.
Ellison EC; O'Dorisio MS; O'Dorisio T; Sparks J; Vasallo L; Woltering EA
Surgery; 1984 Dec; 96(6):1019-26. PubMed ID: 6095476
[TBL] [Abstract][Full Text] [Related]
37. Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination.
Vilardaga JP; De Neef P; Di Paolo E; Bollen A; Waelbroeck M; Robberecht P
Biochem Biophys Res Commun; 1995 Jun; 211(3):885-91. PubMed ID: 7598719
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and in vitro properties of the recombinant rabbit secretin receptor.
Svoboda M; Tastenoy M; De Neef P; Delporte C; Waelbroeck M; Robberecht P
Peptides; 1998; 19(6):1055-62. PubMed ID: 9700755
[TBL] [Abstract][Full Text] [Related]
39. Binding of diphtheria toxin to CHO-K1 and Vero cells is dependent on cell density.
Schaefer EM; Moehring JM; Moehring TJ
J Cell Physiol; 1988 Jun; 135(3):407-15. PubMed ID: 3135292
[TBL] [Abstract][Full Text] [Related]
40. Secretin receptors on neuroblastoma cell membranes: characterization of 125I-labeled secretin binding and association with adenylate cyclase.
Roth BL; Beinfeld MC; Howlett AC
J Neurochem; 1984 Apr; 42(4):1145-52. PubMed ID: 6321661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
